Global Nuclear Medicine/Radiopharmaceuticals Market Size study, By Type (Diagnostic Nuclear Medicine, Therapeutic Nuclear Medicine, Brachytherapy Isotopes), By Application (SPECT Applications, PET Applications, Therapeutic Applications), By Procedural Volume Assessment (Diagnostic Procedures, Therapeutic Procedures), and Regional Forecasts 2022-2028
Global Nuclear Medicine/Radiopharmaceuticals Market is valued approximately USD 4.80 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.0% over the forecast period 2022-2028.
Nuclear medicine is also known as radiopharmaceuticals or medicinal radio compounds, which is a set of pharmaceutical drugs that comprises radioactive isotopes. Nuclear medicine is a form of medical specialty that includes the application of radioactive substances in the diagnosis and treatment of target diseases. The growing incidence and prevalence of target conditions such as cancer, cardiovascular, and neurological disorders, rising awareness of radiopharmaceuticals, and rising development of the alpha-radioimmunotherapy-based targeted cancer treatments are the primary factors that are surging the market demand across the globe. According to the National Cancer Institute, in 2018, cancer was is one of the major reasons for the highest deaths accounting for 18.1 million new cases and 9.5 million cancer-related deaths globally. Also, it is expected that the amount will reach 29.5 million and the number of cancer-related deaths to 16.4 million by the end of 2040. Thereby, the rising prevalence of cancer is propelling demand for radiopharmaceuticals, thus, in turn, impelling the market growth. Moreover, the rising inclination towards the Single photon emission computed tomography (SPECT) and positron emission tomography (PET) scans and the increasing number of initiatives to meet the demand & supply gap of Mo-99 is further accelerating the market growth. However, the short half-life of radiopharmaceuticals and hospital budget cuts, and high equipment costs impede the growth of the market over the forecast period of 2022-2028. Also, the use of radiopharmaceuticals in neurological applications and growing investment in R&D activities are anticipated to act as a catalyzing factor for the market demand during the forecast period.
The key regions considered for the global Nuclear Medicine/Radiopharmaceuticals market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Asia-Pacific is the leading region across the world in terms of market share owing to the development of novel technologies for radioisotope production, growing incidences of Alzheimer’s disease, Parkinson’s disease, and availability of government funding. Whereas, North America is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as the increasing R&D expenditure, as well as the rising presence of the leading market players in the region, would create lucrative growth prospects for the Nuclear Medicine/Radiopharmaceuticals market across the North American region.
Major market players included in this report are:
Cardinal Health Inc.
GE Healthcare Company
Curium SAS
Lantheus Medical Imaging Inc.
Bayer AG
Bracco Imaging Inc.
Eczacэba?э-Monrol Nuclear Products
Nordion Inc.
Advanced Accelerator Applications
NTP Radioisotopes SOC Ltd.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type
Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine
Brachytherapy Isotopes
By Application
SPECT Applications
PET Applications
Therapeutic Applications
By Procedural Volume Assessment
Diagnostic Procedures
Therapeutic Procedures
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Nuclear Medicine/Radiopharmaceuticals Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Nuclear medicine is also known as radiopharmaceuticals or medicinal radio compounds, which is a set of pharmaceutical drugs that comprises radioactive isotopes. Nuclear medicine is a form of medical specialty that includes the application of radioactive substances in the diagnosis and treatment of target diseases. The growing incidence and prevalence of target conditions such as cancer, cardiovascular, and neurological disorders, rising awareness of radiopharmaceuticals, and rising development of the alpha-radioimmunotherapy-based targeted cancer treatments are the primary factors that are surging the market demand across the globe. According to the National Cancer Institute, in 2018, cancer was is one of the major reasons for the highest deaths accounting for 18.1 million new cases and 9.5 million cancer-related deaths globally. Also, it is expected that the amount will reach 29.5 million and the number of cancer-related deaths to 16.4 million by the end of 2040. Thereby, the rising prevalence of cancer is propelling demand for radiopharmaceuticals, thus, in turn, impelling the market growth. Moreover, the rising inclination towards the Single photon emission computed tomography (SPECT) and positron emission tomography (PET) scans and the increasing number of initiatives to meet the demand & supply gap of Mo-99 is further accelerating the market growth. However, the short half-life of radiopharmaceuticals and hospital budget cuts, and high equipment costs impede the growth of the market over the forecast period of 2022-2028. Also, the use of radiopharmaceuticals in neurological applications and growing investment in R&D activities are anticipated to act as a catalyzing factor for the market demand during the forecast period.
The key regions considered for the global Nuclear Medicine/Radiopharmaceuticals market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Asia-Pacific is the leading region across the world in terms of market share owing to the development of novel technologies for radioisotope production, growing incidences of Alzheimer’s disease, Parkinson’s disease, and availability of government funding. Whereas, North America is anticipated to exhibit a significant growth rate over the forecast period 2022-2028. Factors such as the increasing R&D expenditure, as well as the rising presence of the leading market players in the region, would create lucrative growth prospects for the Nuclear Medicine/Radiopharmaceuticals market across the North American region.
Major market players included in this report are:
Cardinal Health Inc.
GE Healthcare Company
Curium SAS
Lantheus Medical Imaging Inc.
Bayer AG
Bracco Imaging Inc.
Eczacэba?э-Monrol Nuclear Products
Nordion Inc.
Advanced Accelerator Applications
NTP Radioisotopes SOC Ltd.
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Type
Diagnostic Nuclear Medicine
Therapeutic Nuclear Medicine
Brachytherapy Isotopes
By Application
SPECT Applications
PET Applications
Therapeutic Applications
By Procedural Volume Assessment
Diagnostic Procedures
Therapeutic Procedures
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028
Target Audience of the Global Nuclear Medicine/Radiopharmaceuticals Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
CHAPTER 1. EXECUTIVE SUMMARY
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global Nuclear Medicine/Radiopharmaceuticals Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global Nuclear Medicine/Radiopharmaceuticals Market, by Type, 2020-2028 (USD Billion)
1.2.3. Global Nuclear Medicine/Radiopharmaceuticals Market, by Applications, 2020-2028 (USD Billion)
1.2.4. Global Nuclear Medicine/Radiopharmaceuticals Market, by Procedural Volume Assessment, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET DYNAMICS
3.1. Nuclear Medicine/Radiopharmaceuticals Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growing prevalence of target conditions
3.1.1.2. Development of alpha-radioimmunotherapy-based targeted cancer treatments
3.1.2. Market Challenges
3.1.2.1. Short half-life of radiopharmaceuticals
3.1.2.2. Hospital budget cuts and high equipment costs
3.1.3. Market Opportunities
3.1.3.1. Use of radiopharmaceuticals in neurological applications
3.1.3.2. Increasing investment in the R&D activities
CHAPTER 4. GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, BY TYPE
6.1. Market Snapshot
6.2. Global Nuclear Medicine/Radiopharmaceuticals Market by Type, Performance - Potential Analysis
6.3. Global Nuclear Medicine/Radiopharmaceuticals Market Estimates & Forecasts by Type 2018-2028 (USD Billion)
6.4. Nuclear Medicine/Radiopharmaceuticals Market, Sub Segment Analysis
6.4.1. Diagnostic Nuclear Medicine
6.4.2. Therapeutic Nuclear Medicine
6.4.3. Brachytherapy Isotopes
CHAPTER 7. GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, BY APPLICATIONS
7.1. Market Snapshot
7.2. Global Nuclear Medicine/Radiopharmaceuticals Market by Applications, Performance - Potential Analysis
7.3. Global Nuclear Medicine/Radiopharmaceuticals Market Estimates & Forecasts by Applications 2018-2028 (USD Billion)
7.4. Nuclear Medicine/Radiopharmaceuticals Market, Sub Segment Analysis
7.4.1. SPECT Applications
7.4.2. PET Applications
7.4.3. Therapeutic Applications
CHAPTER 8. GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, BY PROCEDURAL VOLUME ASSESSMENT
8.1. Market Snapshot
8.2. Global Nuclear Medicine/Radiopharmaceuticals Market by Procedural Volume Assessment, Performance - Potential Analysis
8.3. Global Nuclear Medicine/Radiopharmaceuticals Market Estimates & Forecasts by Procedural Volume Assessment 2018-2028 (USD Billion)
8.4. Nuclear Medicine/Radiopharmaceuticals Market, Sub Segment Analysis
8.4.1. Diagnostic Procedures
8.4.2. Therapeutic Procedures
CHAPTER 9. GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, REGIONAL ANALYSIS
9.1. Nuclear Medicine/Radiopharmaceuticals Market, Regional Market Snapshot
9.2. North America Nuclear Medicine/Radiopharmaceuticals Market
9.2.1. U.S. Nuclear Medicine/Radiopharmaceuticals Market
9.2.1.1. Type estimates & forecasts, 2018-2028
9.2.1.2. Applications estimates & forecasts, 2018-2028
9.2.1.3. Procedural Volume Assessment estimates & forecasts, 2018-2028
9.2.2. Canada Nuclear Medicine/Radiopharmaceuticals Market
9.3. Europe Nuclear Medicine/Radiopharmaceuticals Market Snapshot
9.3.1. U.K. Nuclear Medicine/Radiopharmaceuticals Market
9.3.2. Germany Nuclear Medicine/Radiopharmaceuticals Market
9.3.3. France Nuclear Medicine/Radiopharmaceuticals Market
9.3.4. Spain Nuclear Medicine/Radiopharmaceuticals Market
9.3.5. Italy Nuclear Medicine/Radiopharmaceuticals Market
9.3.6. Rest of Europe Nuclear Medicine/Radiopharmaceuticals Market
9.4. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Market Snapshot
9.4.1. China Nuclear Medicine/Radiopharmaceuticals Market
9.4.2. India Nuclear Medicine/Radiopharmaceuticals Market
9.4.3. Japan Nuclear Medicine/Radiopharmaceuticals Market
9.4.4. Australia Nuclear Medicine/Radiopharmaceuticals Market
9.4.5. South Korea Nuclear Medicine/Radiopharmaceuticals Market
9.4.6. Rest of Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market
9.5. Latin America Nuclear Medicine/Radiopharmaceuticals Market Snapshot
9.5.1. Brazil Nuclear Medicine/Radiopharmaceuticals Market
9.5.2. Mexico Nuclear Medicine/Radiopharmaceuticals Market
9.6. Rest of The World Nuclear Medicine/Radiopharmaceuticals Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Cardinal Health Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. GE Healthcare Company
10.2.3. Curium SAS
10.2.4. Lantheus Medical Imaging Inc.
10.2.5. Bayer AG
10.2.6. Bracco Imaging Inc.
10.2.7. Eczacэba?э-Monrol Nuclear Products
10.2.8. Nordion Inc.
10.2.9. Advanced Accelerator Applications
10.2.10. NTP Radioisotopes SOC Ltd.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
1.2.1. Global Nuclear Medicine/Radiopharmaceuticals Market, by Region, 2020-2028 (USD Billion)
1.2.2. Global Nuclear Medicine/Radiopharmaceuticals Market, by Type, 2020-2028 (USD Billion)
1.2.3. Global Nuclear Medicine/Radiopharmaceuticals Market, by Applications, 2020-2028 (USD Billion)
1.2.4. Global Nuclear Medicine/Radiopharmaceuticals Market, by Procedural Volume Assessment, 2020-2028 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
CHAPTER 2. GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET DEFINITION AND SCOPE
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
CHAPTER 3. GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET DYNAMICS
3.1. Nuclear Medicine/Radiopharmaceuticals Market Impact Analysis (2020-2028)
3.1.1. Market Drivers
3.1.1.1. Growing prevalence of target conditions
3.1.1.2. Development of alpha-radioimmunotherapy-based targeted cancer treatments
3.1.2. Market Challenges
3.1.2.1. Short half-life of radiopharmaceuticals
3.1.2.2. Hospital budget cuts and high equipment costs
3.1.3. Market Opportunities
3.1.3.1. Use of radiopharmaceuticals in neurological applications
3.1.3.2. Increasing investment in the R&D activities
CHAPTER 4. GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET INDUSTRY ANALYSIS
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2018-2028)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economical
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
4.5. Top investment opportunity
4.6. Top winning strategies
CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT
5.1.1. Assessment of the overall impact of COVID-19 on the industry
5.1.2. Pre COVID-19 and post COVID-19 Market scenario
CHAPTER 6. GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, BY TYPE
6.1. Market Snapshot
6.2. Global Nuclear Medicine/Radiopharmaceuticals Market by Type, Performance - Potential Analysis
6.3. Global Nuclear Medicine/Radiopharmaceuticals Market Estimates & Forecasts by Type 2018-2028 (USD Billion)
6.4. Nuclear Medicine/Radiopharmaceuticals Market, Sub Segment Analysis
6.4.1. Diagnostic Nuclear Medicine
6.4.2. Therapeutic Nuclear Medicine
6.4.3. Brachytherapy Isotopes
CHAPTER 7. GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, BY APPLICATIONS
7.1. Market Snapshot
7.2. Global Nuclear Medicine/Radiopharmaceuticals Market by Applications, Performance - Potential Analysis
7.3. Global Nuclear Medicine/Radiopharmaceuticals Market Estimates & Forecasts by Applications 2018-2028 (USD Billion)
7.4. Nuclear Medicine/Radiopharmaceuticals Market, Sub Segment Analysis
7.4.1. SPECT Applications
7.4.2. PET Applications
7.4.3. Therapeutic Applications
CHAPTER 8. GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, BY PROCEDURAL VOLUME ASSESSMENT
8.1. Market Snapshot
8.2. Global Nuclear Medicine/Radiopharmaceuticals Market by Procedural Volume Assessment, Performance - Potential Analysis
8.3. Global Nuclear Medicine/Radiopharmaceuticals Market Estimates & Forecasts by Procedural Volume Assessment 2018-2028 (USD Billion)
8.4. Nuclear Medicine/Radiopharmaceuticals Market, Sub Segment Analysis
8.4.1. Diagnostic Procedures
8.4.2. Therapeutic Procedures
CHAPTER 9. GLOBAL NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, REGIONAL ANALYSIS
9.1. Nuclear Medicine/Radiopharmaceuticals Market, Regional Market Snapshot
9.2. North America Nuclear Medicine/Radiopharmaceuticals Market
9.2.1. U.S. Nuclear Medicine/Radiopharmaceuticals Market
9.2.1.1. Type estimates & forecasts, 2018-2028
9.2.1.2. Applications estimates & forecasts, 2018-2028
9.2.1.3. Procedural Volume Assessment estimates & forecasts, 2018-2028
9.2.2. Canada Nuclear Medicine/Radiopharmaceuticals Market
9.3. Europe Nuclear Medicine/Radiopharmaceuticals Market Snapshot
9.3.1. U.K. Nuclear Medicine/Radiopharmaceuticals Market
9.3.2. Germany Nuclear Medicine/Radiopharmaceuticals Market
9.3.3. France Nuclear Medicine/Radiopharmaceuticals Market
9.3.4. Spain Nuclear Medicine/Radiopharmaceuticals Market
9.3.5. Italy Nuclear Medicine/Radiopharmaceuticals Market
9.3.6. Rest of Europe Nuclear Medicine/Radiopharmaceuticals Market
9.4. Asia-Pacific Nuclear Medicine/Radiopharmaceuticals Market Snapshot
9.4.1. China Nuclear Medicine/Radiopharmaceuticals Market
9.4.2. India Nuclear Medicine/Radiopharmaceuticals Market
9.4.3. Japan Nuclear Medicine/Radiopharmaceuticals Market
9.4.4. Australia Nuclear Medicine/Radiopharmaceuticals Market
9.4.5. South Korea Nuclear Medicine/Radiopharmaceuticals Market
9.4.6. Rest of Asia Pacific Nuclear Medicine/Radiopharmaceuticals Market
9.5. Latin America Nuclear Medicine/Radiopharmaceuticals Market Snapshot
9.5.1. Brazil Nuclear Medicine/Radiopharmaceuticals Market
9.5.2. Mexico Nuclear Medicine/Radiopharmaceuticals Market
9.6. Rest of The World Nuclear Medicine/Radiopharmaceuticals Market
CHAPTER 10. COMPETITIVE INTELLIGENCE
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Cardinal Health Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. GE Healthcare Company
10.2.3. Curium SAS
10.2.4. Lantheus Medical Imaging Inc.
10.2.5. Bayer AG
10.2.6. Bracco Imaging Inc.
10.2.7. Eczacэba?э-Monrol Nuclear Products
10.2.8. Nordion Inc.
10.2.9. Advanced Accelerator Applications
10.2.10. NTP Radioisotopes SOC Ltd.
CHAPTER 11. RESEARCH PROCESS
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
LIST OF TABLES
TABLE 1. Global Nuclear Medicine/Radiopharmaceuticals Market, report scope
TABLE 2. Global Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by Type 2018-2028 (USD Billion)
TABLE 4. Global Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by Applications 2018-2028 (USD Billion)
TABLE 5. Global Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by Procedural Volume Assessment 2018-2028 (USD Billion)
TABLE 6. Global Nuclear Medicine/Radiopharmaceuticals Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 7. Global Nuclear Medicine/Radiopharmaceuticals Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 8. Global Nuclear Medicine/Radiopharmaceuticals Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global Nuclear Medicine/Radiopharmaceuticals Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global Nuclear Medicine/Radiopharmaceuticals Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global Nuclear Medicine/Radiopharmaceuticals Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global Nuclear Medicine/Radiopharmaceuticals Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global Nuclear Medicine/Radiopharmaceuticals Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. Global Nuclear Medicine/Radiopharmaceuticals Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. Global Nuclear Medicine/Radiopharmaceuticals Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 16. U.S. Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 17. U.S. Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 18. U.S. Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 19. Canada Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 20. Canada Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 21. Canada Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 22. UK Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 23. UK Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 24. UK Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 25. Germany Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 26. Germany Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 27. Germany Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 28. RoE Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 29. RoE Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 30. RoE Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 31. China Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 32. China Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 33. China Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 34. India Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 35. India Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 36. India Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 37. Japan Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 38. Japan Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 39. Japan Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 40. RoAPAC Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 41. RoAPAC Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 42. RoAPAC Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 43. Brazil Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 44. Brazil Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 45. Brazil Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 46. Mexico Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 47. Mexico Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 48. Mexico Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 49. RoLA Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 50. RoLA Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 51. RoLA Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 52. Row Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 53. Row Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 54. Row Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global Nuclear Medicine/Radiopharmaceuticals Market
TABLE 56. List of primary sources, used in the study of global Nuclear Medicine/Radiopharmaceuticals Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
TABLE 1. Global Nuclear Medicine/Radiopharmaceuticals Market, report scope
TABLE 2. Global Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by Region 2018-2028 (USD Billion)
TABLE 3. Global Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by Type 2018-2028 (USD Billion)
TABLE 4. Global Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by Applications 2018-2028 (USD Billion)
TABLE 5. Global Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by Procedural Volume Assessment 2018-2028 (USD Billion)
TABLE 6. Global Nuclear Medicine/Radiopharmaceuticals Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 7. Global Nuclear Medicine/Radiopharmaceuticals Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 8. Global Nuclear Medicine/Radiopharmaceuticals Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 9. Global Nuclear Medicine/Radiopharmaceuticals Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 10. Global Nuclear Medicine/Radiopharmaceuticals Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 11. Global Nuclear Medicine/Radiopharmaceuticals Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 12. Global Nuclear Medicine/Radiopharmaceuticals Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 13. Global Nuclear Medicine/Radiopharmaceuticals Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 14. Global Nuclear Medicine/Radiopharmaceuticals Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 15. Global Nuclear Medicine/Radiopharmaceuticals Market by region, estimates & forecasts, 2018-2028 (USD Billion)
TABLE 16. U.S. Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 17. U.S. Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 18. U.S. Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 19. Canada Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 20. Canada Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 21. Canada Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 22. UK Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 23. UK Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 24. UK Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 25. Germany Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 26. Germany Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 27. Germany Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 28. RoE Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 29. RoE Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 30. RoE Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 31. China Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 32. China Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 33. China Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 34. India Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 35. India Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 36. India Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 37. Japan Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 38. Japan Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 39. Japan Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 40. RoAPAC Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 41. RoAPAC Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 42. RoAPAC Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 43. Brazil Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 44. Brazil Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 45. Brazil Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 46. Mexico Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 47. Mexico Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 48. Mexico Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 49. RoLA Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 50. RoLA Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 51. RoLA Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 52. Row Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts, 2018-2028 (USD Billion)
TABLE 53. Row Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 54. Row Nuclear Medicine/Radiopharmaceuticals Market estimates & forecasts by segment 2018-2028 (USD Billion)
TABLE 55. List of secondary sources, used in the study of global Nuclear Medicine/Radiopharmaceuticals Market
TABLE 56. List of primary sources, used in the study of global Nuclear Medicine/Radiopharmaceuticals Market
TABLE 57. Years considered for the study
TABLE 58. Exchange rates considered
LIST OF FIGURES
FIG 1. Global Nuclear Medicine/Radiopharmaceuticals Market, research methodology
FIG 2. Global Nuclear Medicine/Radiopharmaceuticals Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Nuclear Medicine/Radiopharmaceuticals Market, key trends 2021
FIG 5. Global Nuclear Medicine/Radiopharmaceuticals Market, growth prospects 2022-2028
FIG 6. Global Nuclear Medicine/Radiopharmaceuticals Market, porters 5 force model
FIG 7. Global Nuclear Medicine/Radiopharmaceuticals Market, pest analysis
FIG 8. Global Nuclear Medicine/Radiopharmaceuticals Market, value chain analysis
FIG 9. Global Nuclear Medicine/Radiopharmaceuticals Market by segment, 2018 & 2028 (USD Billion)
FIG 10. Global Nuclear Medicine/Radiopharmaceuticals Market by segment, 2018 & 2028 (USD Billion)
FIG 11. Global Nuclear Medicine/Radiopharmaceuticals Market by segment, 2018 & 2028 (USD Billion)
FIG 12. Global Nuclear Medicine/Radiopharmaceuticals Market by segment, 2018 & 2028 (USD Billion)
FIG 13. Global Nuclear Medicine/Radiopharmaceuticals Market by segment, 2018 & 2028 (USD Billion)
FIG 14. Global Nuclear Medicine/Radiopharmaceuticals Market, regional snapshot 2018 & 2028
FIG 15. North America Nuclear Medicine/Radiopharmaceuticals Market 2018 & 2028 (USD Billion)
FIG 16. Europe Nuclear Medicine/Radiopharmaceuticals Market 2018 & 2028 (USD Billion)
FIG 17. Asia pacific Market 2018 & 2028 (USD Billion)
FIG 18. Latin America Nuclear Medicine/Radiopharmaceuticals Market 2018 & 2028 (USD Billion)
FIG 19. Global Nuclear Medicine/Radiopharmaceuticals Market, company Market share analysis (2021)
FIG 1. Global Nuclear Medicine/Radiopharmaceuticals Market, research methodology
FIG 2. Global Nuclear Medicine/Radiopharmaceuticals Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Nuclear Medicine/Radiopharmaceuticals Market, key trends 2021
FIG 5. Global Nuclear Medicine/Radiopharmaceuticals Market, growth prospects 2022-2028
FIG 6. Global Nuclear Medicine/Radiopharmaceuticals Market, porters 5 force model
FIG 7. Global Nuclear Medicine/Radiopharmaceuticals Market, pest analysis
FIG 8. Global Nuclear Medicine/Radiopharmaceuticals Market, value chain analysis
FIG 9. Global Nuclear Medicine/Radiopharmaceuticals Market by segment, 2018 & 2028 (USD Billion)
FIG 10. Global Nuclear Medicine/Radiopharmaceuticals Market by segment, 2018 & 2028 (USD Billion)
FIG 11. Global Nuclear Medicine/Radiopharmaceuticals Market by segment, 2018 & 2028 (USD Billion)
FIG 12. Global Nuclear Medicine/Radiopharmaceuticals Market by segment, 2018 & 2028 (USD Billion)
FIG 13. Global Nuclear Medicine/Radiopharmaceuticals Market by segment, 2018 & 2028 (USD Billion)
FIG 14. Global Nuclear Medicine/Radiopharmaceuticals Market, regional snapshot 2018 & 2028
FIG 15. North America Nuclear Medicine/Radiopharmaceuticals Market 2018 & 2028 (USD Billion)
FIG 16. Europe Nuclear Medicine/Radiopharmaceuticals Market 2018 & 2028 (USD Billion)
FIG 17. Asia pacific Market 2018 & 2028 (USD Billion)
FIG 18. Latin America Nuclear Medicine/Radiopharmaceuticals Market 2018 & 2028 (USD Billion)
FIG 19. Global Nuclear Medicine/Radiopharmaceuticals Market, company Market share analysis (2021)
